AzTrials
AzTrials

Acute Myocardial InfarctionPhase 1NCT00792181

To Relieve Pain and Anxiety - an Intervention Study in Ambulance Services

A Phase 1 study testing Midazolam and Course intervention - a professional development course for caregivers. in people with Acute Myocardial Infarction and Pain, run by Sahlgrenska University Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is an intervention study focusing on both medical and nursing questions. The study is a joint project between the Ambulance services at four cities in West Sweden and Knowledge and research centre, PreHospen at University of Borås. Read more about this study

Who is it for?
Any age
Conditions the study is for
Acute Myocardial Infarction, Pain
What is being tested?
Midazolam and Course intervention - a professional development course for caregivers.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,800 participants
Where
No sites listed yet
Study dates
Jun 2008to Nov 2008
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Child, Adult, Older adult

Who may be able to join

  • Patients in Ambulance service with chest pain and suspicion about acute coronary syndrome.
  • At least 4 on a Coloured Analogue Scale.

Who cannot join

  • Blood pressure less than 100 mmHg
  • Children under 18 years
  • Under the influence of alcohol
  • Under the influence of drugs
  • Treatment with benzodiazepines
  • Disorientated
  • Communication problems
  • Trauma

About this study

Official title: Intervention Study to Relieve Pain and Anxiety in Acute Myocardial Disease Focusing on Treatment With Benzodiazepines(Midazolam)and the Importance of a Caring Relation.

This is an intervention study focusing on both medical and nursing questions. The study is a joint project between the Ambulance services at four cities in West Sweden and Knowledge and research centre, PreHospen at University of Borås. The aim is to prove the importance of a caring relation between a patient and a caregiver in cases when a caregiver treats a patient with benzodiazepines (Midazolam). The overall aim is to show that knowledge and skills in both caring science and medicine can be applied at the same time in order to relieve pain and anxiety in acute myocardial disease.

The nursing intervention involves a professional development course for caregivers. The course is expected to deepen the caregivers' knowledge about the encounter with patients as well as cardiovascular treatment.

Read more

Following questions are formulated:

  1. What are the effects regarding relieving pain and anxiety in acute myocardial disease? B. What are the effects regarding circulatory influence? C. What are the effects regarding patients' experiences of the ambulance services? D. What are the effects regarding number of care days in relation to acute myocardial disease? E. What are the effects of patients' disease complications?
Being tested
Midazolam, Course intervention - a professional development course for caregivers.
Keywords
The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MidazolamDrug

    Midazolam 1 mg: 70 years or more and less than 70 kg Midazolam 2 mg: under 70 years and 70 kg or more

  • Course intervention - a professional development course for caregivers.Other

    The nursing intervention involves a professional development course for caregivers. The course is expected to deepen the caregivers' knowledge about the encounter with patients as well as cardiovascular treatment.

Study groups in NCT00792181
Study groupRoleWhat they receive
1ExperimentalMedical intervention - with benzodiazepines (Midazolam).
Receives: Drug: Midazolam
2ExperimentalCourse intervention - a professional development course for caregivers.
Receives: Other: Course intervention - a professional development course for caregivers.
3ExperimentalCombination of both medical interventions and a professional development course for caregivers.
Receives: Drug: Midazolam; Other: Course intervention - a professional development course for caregivers.
4No interventionNo intervention at all = a control group

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2008 (estimated)
  2. Study startJun 2008
  3. Primary completionNov 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
2,800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00792181
Sponsor's protocol ID
MPA Dnr 151:2008/4564
Status last verified
Nov 2008
First submitted
14 Nov 2008
Last updated
17 Nov 2008
Results posted
No
Data monitoring committee
Yes

Publications

  • Holmberg M, Andersson H, Winge K, Lundberg C, Karlsson T, Herlitz J, Wireklint Sundstrom B. Association between the reported intensity of an acute symptom at first prehospital assessment and the subsequent outcome: a study on patients with acute chest pain and presumed acute coronary syndrome. BMC Cardiovasc Disord. 2018 Nov 28;18(1):216. doi: 10.1186/s12872-018-0957-3.

    PubMed 30486789
  • Wireklint Sundstrom B, Holmberg M, Herlitz J, Karlsson T, Andersson H. Possible effects of a course in cardiovascular nursing on prehospital care of patients experiencing suspected acute coronary syndrome: a cluster randomised controlled trial. BMC Nurs. 2016 Sep 2;15(1):52. doi: 10.1186/s12912-016-0175-1. eCollection 2016.

    PubMed 27594805

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Midazolam and Course intervention - a professional development course for caregivers. in people with Acute Myocardial Infarction and Pain, run by Sahlgrenska University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2008. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00792181, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in